DRDO Builds 300-Bed ICU-Equipped Hospital In Guwahati Within 20 Days swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
DRDO Lab, ISRO Centre Team Up For Impact Tests On Gaganyaan Crew Module Against Space Debris
by Karan Kamble - Jun 4, 2021 12:02 PM
A swarm of satellites and debris around Earth
Snapshot
Space debris poses a threat to human spaceflight and robotic space missions.
A DRDO lab and an ISRO centre have signed an MOU to conduct impact studies on Gaganyaan crew module against space debris.
A laboratory of the Defence Research and Development Organisation (DRDO) and a relatively recent Indian Space Research Organisation (ISRO) centre have come together to conduct special tests for Indiaâs landmark Gaganyaan mission.
DRDOâs Terminal Ballistics Research Laboratory (TBRL) signed a memorandum of understanding (MOU) with ISROâs Human Spaceflight Centre (HSFC) via video conference on 31 March this year.
: Friday, May 28, 2021, 1:55 PM IST
DRDOâs 2-DG anti-COVID-19 drug to be available for Rs 990 per sachet, hospitals to get discount
Photo Credit: PTI
The price of DRDOâs 2DG anti-COVID 19 drug has been fixed at Rs 990 per sachet by pharma major Dr Reddyâs Laboratories, government officials told news agency ANI.
The government officials said the central and state government hospitals would be provided with the medicine at a discounted price, reported ANI.
The price of DRDOâÂÂs 2DG anti-COVID 19 drug has been kept at Rs 990 per sachet by Dr ReddyâÂÂs lab. Govt hospitals, central and state govt would be provided the medicine at a discounted price: Govt officials pic.twitter.com/FEic70fSq5 ANI (@ANI) May 28, 2021
Dr. Reddyâs Laboratories Ltd (IANS)
In the coming few months, Dr Reddyâs Laboratories is targeting to launch its new treatment alternatives for Covid-19 patients that are currently under-development. Moreover, undisturbed deliveries of its current set of products for the infectious disease will be maintained simultaneously as well.
The company has recently expanded the deliveries of several medicines that also include the highly-demanded Remdesivir drug. Recently, they had initiated the Russian Sputnik V Covid-19 vaccine in the country whilst partnering with several organizations such as Defence Research and Development Organization (DRDO).
Dr Reddyâs has the rights for the first 250 million doses of the same in India and the initial quantities are set to come through the imported route from Russia. Additionally, it has forged partnerships with around six manufacturing firms in order to produce the same locally in India.